1
|
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
|
Am J Respir Crit Care Med
|
2011
|
22.39
|
2
|
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
|
N Engl J Med
|
2014
|
10.62
|
3
|
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
|
Am J Respir Crit Care Med
|
2013
|
6.82
|
4
|
Acute exacerbations of idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2007
|
6.71
|
5
|
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
|
Am J Respir Crit Care Med
|
2012
|
5.37
|
6
|
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.
|
Am J Respir Crit Care Med
|
2008
|
3.97
|
7
|
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
|
N Engl J Med
|
2011
|
3.85
|
8
|
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
|
Nat Genet
|
2013
|
3.17
|
9
|
Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2009
|
2.43
|
10
|
Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.
|
Am J Respir Crit Care Med
|
2007
|
2.13
|
11
|
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2010
|
2.03
|
12
|
Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2011
|
2.00
|
13
|
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.
|
Am J Respir Crit Care Med
|
2005
|
1.77
|
14
|
Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease.
|
Chest
|
2005
|
1.72
|
15
|
Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient.
|
Crit Care Med
|
2003
|
1.67
|
16
|
Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
|
J Antimicrob Chemother
|
2006
|
1.61
|
17
|
Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia.
|
Chest
|
2009
|
1.58
|
18
|
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.
|
Eur Respir J
|
2013
|
1.54
|
19
|
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
|
Chest
|
2007
|
1.53
|
20
|
Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital.
|
Infect Control Hosp Epidemiol
|
2009
|
1.52
|
21
|
Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
|
Chest
|
2007
|
1.40
|
22
|
Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.
|
Am J Respir Crit Care Med
|
2004
|
1.27
|
23
|
Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia.
|
Eur J Cardiothorac Surg
|
2007
|
1.26
|
24
|
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs.
|
Respir Med
|
2011
|
1.16
|
25
|
Increasing trend of isolation of non-tuberculous mycobacteria in a tertiary university hospital in South Korea.
|
Tuberc Respir Dis (Seoul)
|
2012
|
1.15
|
26
|
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
|
Thorax
|
2013
|
1.14
|
27
|
Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates.
|
Crit Care
|
2008
|
1.08
|
28
|
Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.
|
Clin Infect Dis
|
2011
|
1.06
|
29
|
The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis.
|
Respir Med
|
2012
|
0.96
|
30
|
Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.
|
Radiology
|
2013
|
0.95
|
31
|
Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia.
|
Rheumatology (Oxford)
|
2010
|
0.94
|
32
|
Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis.
|
Chest
|
2015
|
0.93
|
33
|
Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
|
Chest
|
2013
|
0.93
|
34
|
The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.
|
Chest
|
2015
|
0.92
|
35
|
A case of paratesticular leiomyosarcoma successfully treated with orchiectomy and chemotherapy.
|
Cancer Res Treat
|
2012
|
0.91
|
36
|
Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system.
|
Eur Radiol
|
2012
|
0.91
|
37
|
A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode.
|
Respir Res
|
2011
|
0.90
|
38
|
Association between stress and asthma symptoms: a population-based study.
|
Respirology
|
2004
|
0.90
|
39
|
Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey.
|
Chest
|
2015
|
0.87
|
40
|
Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis.
|
Respir Med
|
2008
|
0.86
|
41
|
Ocular sarcoidosis in a Korean population.
|
J Korean Med Sci
|
2009
|
0.85
|
42
|
Nonspecific interstitial pneumonia versus usual interstitial pneumonia: differences in the density histogram of high-resolution CT.
|
J Comput Assist Tomogr
|
2005
|
0.83
|
43
|
Acute exacerbations in patients with idiopathic pulmonary fibrosis.
|
Respir Res
|
2013
|
0.83
|
44
|
Determinants of respiratory symptom development in patients with chronic airflow obstruction.
|
Respir Med
|
2006
|
0.82
|
45
|
Mycobacterial pulmonary infections in patients with idiopathic pulmonary fibrosis.
|
J Korean Med Sci
|
2012
|
0.82
|
46
|
Comparison of usual interstitial pneumonia and nonspecific interstitial pneumonia: quantification of disease severity and discrimination between two diseases on HRCT using a texture-based automated system.
|
Korean J Radiol
|
2011
|
0.82
|
47
|
Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population.
|
J Korean Med Sci
|
2010
|
0.82
|
48
|
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis.
|
Respir Res
|
2012
|
0.81
|
49
|
Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates.
|
Liver Transpl
|
2011
|
0.80
|
50
|
Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
|
Respir Med
|
2013
|
0.80
|
51
|
Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
|
Respirology
|
2011
|
0.80
|
52
|
Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis.
|
Lung
|
2013
|
0.80
|
53
|
Clinical characteristics of idiopathic pulmonary fibrosis patients with diabetes mellitus: the national survey in Korea from 2003 to 2007.
|
J Korean Med Sci
|
2012
|
0.80
|
54
|
Idiopathic nonspecific interstitial pneumonia: changes in high-resolution computed tomography on long-term follow-up.
|
J Comput Assist Tomogr
|
2012
|
0.79
|
55
|
Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence].
|
Int J Tuberc Lung Dis
|
2013
|
0.78
|
56
|
Elevated serum CA-125 levels in patients with non-tuberculous mycobacterial lung disease.
|
Respirology
|
2010
|
0.78
|
57
|
Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
|
Lung Cancer
|
2002
|
0.78
|
58
|
A simple and easy home-based pulmonary rehabilitation programme for patients with chronic lung diseases.
|
Monaldi Arch Chest Dis
|
2005
|
0.78
|
59
|
Transmission of Multidrug-resistant Tuberculosis Confirmed by Endobronchial Ultrasound Biopsy of a Mediastinal Lymph Node and DNA Fingerprinting Analysis.
|
J Bronchology Interv Pulmonol
|
2010
|
0.78
|
60
|
A nationwide survey of lymphangioleiomyomatosis in Korea: recent increase in newly diagnosed patients.
|
J Korean Med Sci
|
2010
|
0.78
|
61
|
Usefulness of quantitative endotracheal aspirate cultures in intensive care unit patients with suspected pneumonia.
|
J Korean Med Sci
|
2011
|
0.77
|
62
|
Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia.
|
J Korean Med Sci
|
2013
|
0.77
|
63
|
Adequately washed bronchoscope does not induce false-positive amplification tests on bronchial aspirates in the diagnosis of pulmonary tuberculosis.
|
Chest
|
2002
|
0.77
|
64
|
Nontuberculous mycobacterial pulmonary infection in patients with idiopathic interstitial pneumonias: comparison with patients without idiopathic interstitial pneumonias.
|
J Comput Assist Tomogr
|
2014
|
0.77
|
65
|
Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis.
|
Sarcoidosis Vasc Diffuse Lung Dis
|
2015
|
0.76
|
66
|
Recovery from lung injury in survivors of acute respiratory distress syndrome: difference between pulmonary and extrapulmonary subtypes.
|
Intensive Care Med
|
2004
|
0.76
|
67
|
ADAM33 gene polymorphisms are associated with the risk of idiopathic pulmonary fibrosis.
|
Lung
|
2014
|
0.76
|
68
|
Evolving Early Lung Cancers Detected During Follow-Up of Idiopathic Interstitial Pneumonia: Serial CT Features.
|
AJR Am J Roentgenol
|
2015
|
0.76
|
69
|
Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.76
|
70
|
Newly detected pulmonary nontuberculous mycobacterial infection and peripheral lung cancers in patients during follow-up of idiopathic interstitial pneumonia: comparison of CT findings.
|
Medicine (Baltimore)
|
2015
|
0.75
|
71
|
Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases.
|
J Korean Med Sci
|
2011
|
0.75
|
72
|
Is hypercapnea a predictor of better survival in the patients who underwent mechanical ventilation for chronic obstructive pulmonary disease (COPD)?
|
Korean J Intern Med
|
2006
|
0.75
|
73
|
Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
74
|
Idiopathic nonspecific interstitial pneumonia: an unrecognized autoimmune disease?
|
Am J Respir Crit Care Med
|
2007
|
0.75
|
75
|
The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
|
Sarcoidosis Vasc Diffuse Lung Dis
|
2016
|
0.75
|
76
|
Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer.
|
Lung Cancer
|
2003
|
0.75
|
77
|
Clinical validation of the lower limit of normal in lung diffusing capacity: is the lower 5th percentile really the best cut-off value?
|
Respir Physiol Neurobiol
|
2009
|
0.75
|
78
|
Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.75
|
79
|
Preliminary Results of Paclitaxel, Cisplatin and Concurrent High-Dose Radiation Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
|
Cancer Res Treat
|
2002
|
0.75
|